The content discusses various updates within the pharmaceutical industry, including Congress abandoning reform efforts on pharmacy middlemen, the success of an obesity medication in a Phase 2 clinical study, and ongoing battles between drug makers and pharmacy benefit managers. Despite the gray skies, the article emphasizes the importance of embracing each day like a gift and offers maple bourbon as a stimulating choice to kickstart the day. The decision by Congress is seen as a missed opportunity for bipartisan healthcare reform. The success of the obesity medication from Viking Therapeutics adds to the competition in the obesity drug market.
Source link
STAT+: Pharmalittle: We’re reading about Congress punts PBM reform, another obesity drug and more
